Articles

Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies

John Theurer Cancer Center, Hackensack, NJ, USA
UCSF, San Francisco, CA, USA
Winship Cancer Institute of Emory University, Atlanta, GA, USA
Winship Cancer Institute of Emory University, Atlanta, GA, USA
Washington University School of Medicine, St. Louis, MO, USA
Weill Cornell Medical College, New York, NY, USA
Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA
Mount Sinai Medical Center, New York, NY, USA
Onyx Pharmaceuticals Inc., South San Francisco, CA, USA
Onyx Pharmaceuticals Inc., South San Francisco, CA, USA
Winship Cancer Institute of Emory University, Atlanta, GA, USA
Vol. 98 No. 11 (2013): November, 2013 https://doi.org/10.3324/haematol.2013.089334